Centessa Pharmaceuticals Q2 EPS $(0.65)
Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.65) per share.
ToughBuilt Industries Q2 EPS $(0.09) Misses $(0.06) Estimate, Sales $15.90M Beat $13.00M Estimate
ToughBuilt Industries (NASDAQ:TBLT) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.06) by 50 percent. This is a 18.18 percent increase over losses of $(0.11) per share
Teligent Q2 EPS $(0.14) Misses $(0.13) Estimate, Sales $10.43M Miss $10.49M Estimate
Teligent (NASDAQ:TLGT) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 90.91 percent increase over losses of $(1.54) per share from the
Ecoark Holdings Q1 EPS $0.10, Sales $6.90M
Ecoark Holdings (NASDAQ:ZEST) reported quarterly earnings of $0.10 per share. The company reported $6.90 million in sales this quarter.
ATAI Life Sciences Q2 EPS $(0.37) Misses $0.01 Estimate
ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.01 by 3800 percent.
Quarterhill to Acquire Electronics Transaction Consultants for $150M Cash
ETC has been a leading provider of tolling and mobility systems for more than 20 years to some of the largest tolling authorities in the U.S., including in Texas, California and Illinois. ETC's
Entera Bio Q2 EPS $(0.20) Misses $(0.12) Estimate, Sales $109.00K Beat $90.00K Estimate
Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.12) by 66.67 percent. This is a 17.65 percent decrease over losses of $(0.17) per share from the
Sonnet BioTherapeutics Q3 EPS $(0.27) Up From $(0.44) YoY, Has $6M Cash on Hand
Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.27) per share. This is a 38.64 percent increase over losses of $(0.44) per share from the same period last year.
Digital Media Solutions to Evaluate Potential Strategic Alternatives
Digital Media Solutions, Inc. (NYSE:DMS), a leading provider of technology-enabled digital performance advertising solutions connecting consumers and advertisers, today announced that its Board of Directors has initiated
BiomX Q2 EPS $(0.30) Beats $(0.37) Estimate
BiomX (AMEX:PHGE) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 11.11 percent decrease over losses of $(0.27) per share from the same